$113.46
6.77% today
Nasdaq, Apr 04, 09:17 pm CET
ISIN
US7599161095
Symbol
RGEN

Repligen Corporation Stock price

$121.70
-33.68 21.68% 1M
-17.34 12.47% 6M
-22.24 15.45% YTD
-55.62 31.37% 1Y
-65.21 34.89% 3Y
+23.49 23.92% 5Y
+91.45 302.31% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-9.22 7.04%
ISIN
US7599161095
Symbol
RGEN
Sector
Industry

Key metrics

Market capitalization $6.83b
Enterprise Value $6.76b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 46.48
EV/Sales (TTM) EV/Sales 10.66
P/S ratio (TTM) P/S ratio 10.77
P/B ratio (TTM) P/B ratio 3.46
Revenue growth (TTM) Revenue growth 0.33%
Revenue (TTM) Revenue $634.44m
EBIT (operating result TTM) EBIT $24.31m
Free Cash Flow (TTM) Free Cash Flow $145.50m
Cash position $757.36m
EPS (TTM) EPS $-0.46
P/E forward 135.22
P/S forward 9.78
EV/Sales forward 9.68
Short interest 7.90%
Show more

Is Repligen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Repligen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Repligen Corporation forecast:

13x Buy
65%
7x Hold
35%

Analyst Opinions

20 Analysts have issued a Repligen Corporation forecast:

Buy
65%
Hold
35%

Financial data from Repligen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
634 634
0% 0%
100%
- Direct Costs 346 346
0% 0%
55%
288 288
1% 1%
45%
- Selling and Administrative Expenses 135 135
28% 28%
21%
- Research and Development Expense 43 43
0% 0%
7%
111 111
19% 19%
17%
- Depreciation and Amortization 87 87
1% 1%
14%
EBIT (Operating Income) EBIT 24 24
52% 52%
4%
Net Profit -26 -26
172% 172%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Repligen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repligen Corporation Stock News

Positive
Seeking Alpha
15 days ago
I reiterate a 'buy' rating for Repligen with a one-year price target of $175 per share, driven by strong bioprocessing market recovery. Repligen reported 3% organic revenue growth and 13% growth in non-COVID business, with record-high order intakes since Q2 FY22. The acquisition of 908 Devices' bioprocessing analytics portfolio enhances Repligen's process analytical technology, adding significa...
Neutral
GlobeNewsWire
about one month ago
Portfolio includes PAT devices for real-time process monitoring, control and analysis Portfolio includes PAT devices for real-time process monitoring, control and analysis
Neutral
Business Wire
about one month ago
WALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer in purpose-built handheld and desktop devices for chemical analysis, announce that Repligen has purchased 908 Devices' desktop portfolio of four devices for bioprocessing process analytical technolo...
More Repligen Corporation News

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Head office United States
CEO Olivier Loeillot
Employees 1,778
Founded 1981
Website www.repligen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today